We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.85 | 6.70 | 7.00 | 6.85 | 6.85 | 6.85 | 1,026,050 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -6.72 | 41.12M |
From Apr 2019 to Apr 2024
TIDMKMK
RNS Number : 4737X
Kromek Group PLC
28 August 2015
28 August 2015
Kromek Group plc
Total Voting Rights
In conformity with the FCA's Disclosure and Transparency Rules, Kromek Group plc ("Kromek" or the "Company") confirms the following:
As at 28 August 2015 Kromek's issued share capital consists of 152,186,082 ordinary shares of 1 pence each ("Ordinary Shares"). The Company holds no Ordinary Shares in treasury and accordingly the total number of current voting rights in the Company is 152,186,082 Ordinary Shares.
The above figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.
Enquiries:
Kromek Group plc Arnab Basu, CEO +44 (0)1740 626 Derek Bulmer, CFO 060 Cenkos Securities plc Bobbie Hilliam (NOMAD) +44 (0)20 7397 Julian Morse (Sales) 8900 Luther Pendragon Ltd Harry Chathli, Claire Norbury, Alexis +44 (0)20 7618 Gore 9100
About Kromek Group plc
Kromek Group plc is a UK technology company (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT"). Using its core CZT technology, Kromek designs develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group's business model provides a vertically integrated technology offering to customers, from the growth of CZT crystals to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
The Group has operations in the UK, Germany and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
Currently, the Group has over a hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRFVLFLEVFFBBL
(END) Dow Jones Newswires
August 28, 2015 07:13 ET (11:13 GMT)
1 Year Kromek Chart |
1 Month Kromek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
